Filing Details

Accession Number:
0001179110-17-015343
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2017-12-13 19:44:27
Reporting Period:
2017-12-06
Accepted Time:
2017-12-13 19:44:27
Original Submission Date:
2017-12-08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
805928 Axogen Inc. AXGN Electromedical & Electrotherapeutic Apparatus (3845) 411301878
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1530935 Mark Jamie Grooms 13631 Progress Boulevard
Suite 400
Alachua FL 32615
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-12-06 21,290 $26.22 344,317 No 4 S Direct
Common Stock Disposition 2017-12-07 33,500 $26.47 310,817 No 4 S Direct
Common Stock Disposition 2017-12-08 31,805 $26.37 279,012 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $27.00. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  2. These shares of common stock include 132,883 shares held by the Jamie Grooms Trust, of which Mr. Grooms is the trustee.
  3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.95. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.15 to $26.70. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  5. These shares of common stock include 108,883 shares held by the Jamie Grooms Trust, of which Mr. Grooms is the trustee.
  6. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017.
  7. Amended as a result of 2,300 shares sold on December 7, 2017 inadvertently not being disclosed. Such December 7, 2017 transaction has been revised resulting in a change in the aggregate number of shares sold and the weighted average sale price for such day, along with change in holdings after the December 7 and 8, 2017 transactions.